SARAH LAMARCA: Open Payments
NPI 1689150278 · SANDUSKY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$31,387 in 112 payments from 12 companies in 2025. Trend: 2023 $10,778 · 2024 $27,816 · 2025 $31,387
Speaker / faculty: $24,458Food & beverage: $2,697Consulting: $2,500Travel & lodging: $1,732
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 32 | $19,008 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 35 | $10,268 |
| ABBVIE INC. | 16 | $1,517 |
| Neurocrine BioSciences, Inc. | 8 | $159 |
| E.R. Squibb & Sons, L.L.C. | 6 | $98 |
| Alkermes, Inc. | 4 | $79 |
| Indivior Inc. | 2 | $66 |
| Lundbeck LLC | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
Products named: UZEDY, CAPLYTA, AUSTEDO XR, VRAYLAR, INGREZZA, COBENFY, ARISTADA, SUBLOCADE.
Industry payments across OH — which companies pay providers there.
